FN2 Earnings Intelligence
Elevance Health Inc. cash flow (quarterly)
Elevance Health Inc. (ELV) Cash Flow (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $7,500 | $8,560 | $8,713 | $9,657 | $10,232 | - | - |
| + Debt | $28,360 | $28,538 | $31,353 | $31,492 | $30,669 | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $48,891 | $49,776 | $50,711 | $50,181 | $50,474 | $49,263.5 | $48,328.5 |
| % Growth | - | - | - | - | - | -2.9% | - |
| Gross Profit | $43,908 | $44,483 | $45,331 | $44,718 | $44,982 | - | - |
| % Margin | 89.8% | 89.4% | 89.4% | 89.1% | 89.1% | - | - |
| EBITDA | - | - | - | - | - | - | - |
| % Margin | - | - | - | - | - | - | - |
| Net Income | $2,183 | $1,743 | $1,189 | $1,764 | $1,463 | - | - |
| % Margin | 4.5% | 3.5% | 2.3% | 3.5% | 2.9% | - | - |
| Diluted EPS | $9.61 | $7.72 | $5.32 | $8.00 | $6.71 | $4.73 | $2.54 |
| % Growth | - | - | - | - | - | -11.1% | - |
| Operating Cash Flow | $1,017 | - | - | $4,332 | - | - | - |
| CapEx | $196 | - | - | $235 | - | - | - |
| Free Cash Flow | $821 | - | - | $4,097 | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $48,891 | $49,776 | $50,711 | $50,181 | $50,474 | $49,263.5 | $48,328.5 |
| Gross Profit | $43,908 | $44,483 | $45,331 | $44,718 | $44,982 | - | - |
| EBITDA | - | - | - | - | - | - | - |
| Net Income | $2,183 | $1,743 | $1,189 | $1,764 | $1,463 | - | - |
| Diluted EPS | $9.61 | $7.72 | $5.32 | $8.00 | $6.71 | $4.73 | $2.54 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $7,500 | $8,560 | $8,713 | $9,657 | $10,232 |
| Short-term Debt | $250 | $360 | $180 | $724 | $0 |
| Long-term Debt | $28,110 | $28,178 | $31,173 | $30,768 | $30,669 |
| Total Debt | $28,360 | $28,538 | $31,353 | $31,492 | $30,669 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1,017 | - | - | $4,332 | - |
| Capital Expenditure | $196 | - | - | $235 | - |
| Free Cash Flow | $821 | - | - | $4,097 | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 89.8% | 89.4% | 89.4% | 89.1% | 89.1% |
| EBITDA Margin | - | - | - | - | - |
| Net Margin | 4.5% | 3.5% | 2.3% | 3.5% | 2.9% |
| FCF Margin | 1.7% | - | - | 8.2% | - |
| Diluted EPS Growth | - | - | - | - | - |